Good things are coming for us long term investors, the shorts cannot keep their short positions for too long as the CTB rates are too high and the stock won't go too much lower.
The company is working hard on researching the next generation of drug delivery technology to help treat people with various medical conditions (i.e. Arthritis, Pre-eclampsia, etc) as well as medical diagnosis (i.e. using robot pill in place of traditional colonscopy).
Progenity are working with multiple companies to achieve their goals and they have plenty of money for operation.
Bottom line:
Hold strong, the best is yet to come!$Progenity, Inc.(PROG)$